Results 11 to 20 of about 1,675 (195)
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients [PDF]
mBio, 2020 Lyme disease is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 infections annually. Antibiotic intervention cures Lyme disease in the majority of cases; however, 10 to 20% of patients develop ...
Madeleine Morrissette +10 more
doaj +2 more sources
Case Reports in Transplantation, 2020 The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that have wide variety of clinical and histological presentations. The management of PTLDs is challenging due to variety of involvement sites and histological
S. Gandhi +5 more
doaj +2 more sources
BMC Infectious Diseases, 2022 Background Patients with Lyme borreliosis (LB) may report persisting non-specific symptoms such as fatigue, widespread musculoskeletal pain or cognitive difficulties.
Laurence Geebelen +12 more
doaj +3 more sources
Frontiers in Medicine, 2017 BackgroundThe increased incidence and geographic expansion of Lyme disease has made it the most common vector-borne infection in North America. Posttreatment Lyme disease syndrome (PTLDS) represents a subset of patients who remain ill following standard ...
Alison W. Rebman +6 more
doaj +2 more sources
Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome
Life, 2023 Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy.
Kristyna Sloupenska +10 more
doaj +2 more sources
Update of the Swiss guidelines on post-treatment Lyme disease syndrome [PDF]
Swiss Medical Weekly, 2016 Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
Johannes Nemeth +14 more
doaj +4 more sources
Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis [PDF]
Chronic Diseases and Translational Medicine, 2023 Lyme disease is the most common vector‐borne illness in the United States and has been causing significant morbidity since its discovery in 1977. It is well‐documented that about 10% of patients properly treated with antibiotics never fully recover, but ...
Natalie A. Bai, Christie S. Richardson
doaj +2 more sources
Saudi Journal of Anaesthesia, 2018 A subset of patients who had Lyme disease experience postinfectious signs or symptoms called post-treatment Lyme disease syndrome (PTLDS). PTLDS is a chronic condition including pain in joints and muscles, neurological symptoms including demyelinating ...
Stephanie Lim, Sakura Kinjo
doaj +2 more sources
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium [PDF]
Archives of Public Health, 2017 Background In Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking.
Laurence Geebelen +8 more
doaj +2 more sources
Posttransplant Lymphoproliferative Disorders [PDF]
Advances in Hematology, 2012 Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations.
Hazem A. H. Ibrahim, Kikkeri N. Naresh
doaj +2 more sources